COA in Progress
Scientific Background & Mechanism
LL-37 is a 37-amino-acid cationic peptide derived from the C-terminal region of human cathelicidin antimicrobial protein hCAP18. It is the principal human cathelicidin peptide and is produced by several cell types, including neutrophils and epithelial cells.
LL-37 is widely investigated as a host-defense peptide because its biological activity extends beyond direct antimicrobial effects. Research has examined its interactions with microbial membranes, inflammatory signaling, chemotaxis, epithelial-cell responses, angiogenesis, and tissue-remodeling processes.
Its cationic and amphipathic properties allow LL-37 to interact with lipid membranes and influence membrane integrity under certain experimental conditions. LL-37 can also interact with bacterial lipopolysaccharide (LPS) and has been studied for its ability to modify endotoxin-associated signaling.
LL-37 additionally participates in cell-signaling pathways. Experimental work has demonstrated chemotactic activity involving FPRL1/FPR2-related signaling, including effects on neutrophils, monocytes, and T cells.
Its effects can be highly dependent on concentration and experimental environment, and LL-37 can exhibit both pro- and anti-inflammatory properties as well as cytotoxicity in some cellular systems.
Research Applications
Potential laboratory and preclinical research areas include:
Innate immune-system research
Host-defense peptide characterization
Antimicrobial peptide research
Peptide–membrane interaction studies
Bacterial membrane-permeability models
LPS/endotoxin interaction research
Inflammatory-signaling studies
Chemotaxis and immune-cell signaling
FPR2/FPRL1-associated signaling
Epithelial-cell response models
Host–microorganism interaction studies
Biofilm-related laboratory research
Cellular stress-response research
Peptide structure and stability studies
Analytical peptide identification
HPLC purity characterization
LC-MS/mass-spectrometry identity analysis
Because LL-37 has multiple biological activities, experimental results should be interpreted according to the concentration, biological model, environmental conditions, and analytical methodology used.
Laboratory Reconstitution Reference
For laboratory research only.
When LL-37 requires preparation for an analytical or experimental procedure, use an appropriate laboratory-grade solvent or buffer demonstrated to be compatible with the peptide and intended analytical method.
Use calibrated laboratory equipment and controlled or aseptic handling procedures where required by the research protocol.
Laboratory documentation should record the:
Solvent or buffer used
Prepared laboratory concentration
Preparation date
Sample identifier
Lot / batch number
Storage conditions
Relevant experimental conditions
Prepared research samples should be handled according to validated peptide-stability information and the laboratory's established sample-handling procedures.
No human or veterinary dosing, injection, administration, or treatment instructions are provided.
Storage
Store LL-37 according to the conditions established by the applicable product specification, manufacturer documentation, and validated peptide-stability information.
Protect the research material from conditions that may compromise peptide integrity, including inappropriate temperature, moisture, contamination, excessive environmental exposure, or repeated temperature cycling.
Prepared laboratory samples should be maintained under conditions validated for the particular solvent or buffer, concentration, analytical method, and duration of the experiment.
Because peptide structure, aggregation, degradation, and biological activity may be influenced by experimental conditions, laboratories should document preparation and storage parameters as part of appropriate sample traceability.
Scientific References
LL-37 has an extensive scientific literature covering its role as a human cathelicidin and multifunctional host-defense peptide. Reviews describe its antimicrobial properties together with its involvement in chemotaxis, inflammatory regulation, epithelial responses, and other innate-immune processes.
Experimental research has demonstrated that LL-37 can recruit immune cells through FPRL1-associated signaling, providing evidence that its biological functions extend beyond direct microbial membrane activity.
Research has also characterized LL-37 as an LPS-neutralizing and pleiotropic peptide, with experimental effects involving inflammatory signaling and cellular responses.
More recent reviews continue to emphasize the context-dependent nature of LL-37 activity, including its antimicrobial, immunomodulatory, inflammatory, and cytotoxic properties.
For your Ivarah Labs LL-37 product, product-specific claims—including identity, purity percentage, net peptide content, appearance, HPLC results, LC-MS/mass-spectrometry confirmation, sterility, endotoxin testing, or other analytical specifications—should only be populated using results from the corresponding batch-specific laboratory Certificate of Analysis.
Research Use Only — Not for Human Consumption. Not intended for medical, diagnostic, therapeutic, cosmetic, veterinary, antimicrobial-treatment, or performance-enhancement use.